A Comeback for Zantac?
In December of last year, the federal court judge overseeing the MDL relating to Zantac claims effectively dismissed all cases against GSK. This was most certainly the worst news possible, but can Zantac claims possibly make a comeback? Potentially yes, with a few serious caveats. Even though Judge Rosenberg’s ruling on the admissibility of expert …